Download PDF
Neuropediatrics 2007; 38(2): 83-87
DOI: 10.1055/s-2007-984446
Original Article

Georg Thieme Verlag KG Stuttgart · New York

Is Ethosuximide a Risk Factor for Generalised Tonic-clonic Seizures in Absence Epilepsy?

B. Schmitt 1 , T. Kovacevic-Preradovic 1 , H. Critelli 1 , L. Molinari 1
  • 1University Children's Hospital, Clinical Neurophysiology, Zurich, Switzerland
Further Information

Publication History

received 9.7.2006

accepted 21.5.2007

Publication Date:
22 August 2007 (online)

    Permissions and Reprints

Abstract

The occurrence of generalised tonic-clonic seizures (GTCS) was investigated in patients with absence epilepsy (AE), evaluating the opinion that ethosuximide does not protect against GTCS. Our retrospective study included 238 patients with absences and generalised 3-Hz spike waves (SW). We analysed the efficacy of antiepileptic drugs (AED) and the occurrence of GTCS before, during and after treatment. We surveyed family history, treatment delay and EEG findings. Family history of epilepsy was positive in 28%. Children with 3-Hz SW lasting >10 s suffered less frequently from GTCS (p=0.002). Photosensitivity (3-Hz SW during photic stimulation) recorded in 47 children was more frequent in juvenile AE (p=0.0001), but not associated with higher rates of GTCS. GTCS occurred in 27 children (11%) before treatment, in 14 (5.8%) during treatment and in 8 (4.8%) after tapering AED. Valproate and ethosuximide monotherapy were equally effective on absences, carrying the same low risk of GTCS during treatment (2 valproate, 1 ethosuximide). Most GTCS occurred on drug combinations considered effective against GTCS. Risk factors for relapses after tapering AED were photosensitivity (p=0.002) and GTCS during treatment (p=0.02). GTCS are rare in patients with typical AE. Our data do not support the current opinion that ethosuximide is inefficacious on GTCS in AE.

Key words

Absence epilepsy - tonic clonic epilepsy - ethosuximide - children

References

  • 1 Bartolomei F, Roger J, Bureau M, Genton P, Dravet C, Viallat D. et al . Prognostic factors for childhood and juvenile absence epilepsies.  Eur Neurol. 1997;  37 169-175
    PubMedGoogle Scholar
  • 2 Baykan B, Matur Z, Gurses C, Aykutlu E, Gokyigit A. Typical absence seizures triggered by photosensitivity.  Epilepsia. 2005;  46 159-163
    PubMedGoogle Scholar
  • 3 Berg AT, Shinnar S, Levy SR, Testa FM, Smith-Rapaport S, Beckerman B. et al . Two-year remission and subsequent relapse in children with newly diagnosed epilepsy.  Epilepsia. 2001;  42 1553-1562
    CrossrefPubMedGoogle Scholar
  • 4 Berkovic SF. Childhood absence epilepsy and juvenile absence epilepsy. In: Wyllie E (Eds), The treatment of epilepsy Principles and practice. Philadelphia London: Lea & Febiger 1993: 547-551
    Google Scholar
  • 5 Browne TR, Dreifuss FE, Dyken PR, Goode DJ, Penry JK, Porter RJ. et al . Ethosuximide in the treatment of absence (peptit mal) seizures.  Neurology. 1975;  25 515-524
    CrossrefPubMedGoogle Scholar
  • 6 Buoni S, Grosso S, Fois A. Lamotrigine in typical absence epilepsy.  Brain Dev. 1999;  21 303-306
    CrossrefPubMedGoogle Scholar
  • 7 Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.  Epilepsia. 2004;  45 1049-1053
    CrossrefPubMedGoogle Scholar
  • 8 Covanis A, Skiadas K, Loli N, Lada C, Theodorou V. Absence epilepsy: early prognostic signs.  Seizure. 1992;  1 281-289
    CrossrefPubMedGoogle Scholar
  • 9 Dieterich E, Baier WK, Doose H, Tuxhorn I, Fichsel H. Longterm follow-up of childhood epilepsy with absences. I. Epilepsy with absences at onset.  Neuropediatrics. 1985;  16 149-154
    PubMedGoogle Scholar
  • 10 Dieterich E, Doose H, Baier WK, Fichsel H. Longterm follow-up of childhood epilepsy with absences. II. Absence-epilepsy with initial grand mal.  Neuropediatrics. 1985;  16 155-158
    PubMedGoogle Scholar
  • 11 Doose H. Epilepsien im Kindes- und Jugendalter [Epilepsies in childhood and adolescence]. Hamburg: Desitin Arzneimittel GmbH 1998
  • 12 Eeg-Olofsson O, Petersen I, Sellden U. The development of the electroencephalogram in normal children from the age of 1 through 15 years. Paroxysmal activity.  Neuropaediatrie. 1971;  2 375-404
    PubMedGoogle Scholar
  • 13 Fisher RS, Harding G, Erba G, Barkley GL, Wilkins A. Photic- and pattern-induced seizures: a review for the Epilepsy Foundation of America Working Group.  Epilepsia. 2005;  46 1426-1441
    CrossrefPubMedGoogle Scholar
  • 14 Frank LM, Enlow T, Holmes GL, Manasco P, Concannon S, Chen C. et al . Lamictal (lamotrigine) monotherapy for typical absence seizures in children.  Epilepsia. 1999;  40 973-979
    PubMedGoogle Scholar
  • 15 Friedel B, Lempp R. Grand-mal-Provokation bei der Behandlung kindlicher petit-mal mit Oxazolidinen oder Succinimiden und ihre therapeutischen Konsequenzen [Grand mal provocation in the treatment of petit mal in children with oxazolidines or succinimides and its therapeutic consequences].  Z Kinderheilkd. 1962;  87 42-51
    CrossrefPubMedGoogle Scholar
  • 16 Glauser TA. Succinimides Adverse effects. In: Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds), Antiepileptic Drugs 5th edn. Philadelphia Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Lippincott Williams & Wilkins 2002: 658-664
    Google Scholar
  • 17 Gordon N. Treatment of epilepsy with alpha-ethyl-alpha-methyl-succinimide (P.M. 671).  Neurology. 1961;  11 266-268
    PubMedGoogle Scholar
  • 18 Grosso S, Galimberti D, Vezzosi P, Farnetani M, Bartolo RM Di, Bazzotti S. et al . Childhood absence epilepsy: evolution and prognostic factors.  Epilepsia. 2005;  46 1796-1801
    CrossrefPubMedGoogle Scholar
  • 19 Guiwer J, Valenti MP, Bourazza A, Hirsch E. Loiseau P Prognosis of idiopathic absence epilepsies. In: Jallon P (Ed), Prognosis of epilepsies. Paris: John Libbey Eurotext 2003: 249-257
    Google Scholar
  • 20 Hedstrom A, Olsson I. Epidemiology of absence epilepsy: EEG findings and their predictive value.  Pediatr Neurol. 1991;  7 100-104
    CrossrefPubMedGoogle Scholar
  • 21 ILAE CoCaTot . Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.  Epilepsia. 1989;  30 389-399
    CrossrefPubMedGoogle Scholar
  • 22 Jeavons PM. Harding GFA Photosensitive epilepsy. London Philadelphia: Spastics International Medical Publications 1975
  • 23 Loiseau P, Duche B, Pedespan JM. Absence epilepsies.  Epilepsia. 1995;  36 1182-1186
    CrossrefPubMedGoogle Scholar
  • 24 Lorentzdehaas AM, Kuilman M. Ethosuximide (alpha-ethyl-alpha-methylsuccinimide) and grand mal.  Epilepsia. 1964;  23 90-96
    PubMedGoogle Scholar
  • 25 Olsson I. Epidemiology of absence epilepsy. I. Concept and incidence.  Acta Paediatr Scand. 1988;  77 860-866
    PubMedGoogle Scholar
  • 26 Panayiotopoulos CP. Typical absence seizures and their treatment.  Arch Dis Child. 1999;  81 351-355
    PubMedGoogle Scholar
  • 27 Pearl PL, Holmes GL. Absence seizures. In: Pellock JM, Dodson WE, Bourgeois BFD (Eds), Pediatric epilepsy. New York: Demos 2004: 219-231
    Google Scholar
  • 28 Posner EB, Mohamed K, Marson AG. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.  Cochrane Database Syst Rev. 2003;  CD003032
    PubMedGoogle Scholar
  • 29 Todorov AB, Lenn NJ, Gabor AJ. Exacerbation of generalized nonconvulsive seizures with ethosuximide therapy.  Arch Neurol. 1978;  35 389-391
    PubMedGoogle Scholar
  • 30 Waltz S, Christen HJ, Doose H. The different patterns of the photoparoxysmal response - a genetic study.  Electroencephalogr Clin Neurophysiol. 1992;  83 138-145
    CrossrefPubMedGoogle Scholar
  • 31 Wirrell E, Camfield C, Camfield P, Dooley J. Prognostic significance of failure of the initial antiepileptic drug in children with absence epilepsy.  Epilepsia. 2001;  42 760-763
    CrossrefPubMedGoogle Scholar
  • 32 Wirrell EC, Camfield CS, Camfield PR, Gordon KE, Dooley JM. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy.  Neurology. 1996;  47 912-918
    CrossrefPubMedGoogle Scholar
  • 33 Wolf P, Goosses R. Relation of photosensitivity to epileptic syndromes.  J Neurol Neurosurg Psychiatry. 1986;  49 1386-1391
    CrossrefPubMedGoogle Scholar
  • 34 Wolf P, Inoue Y. Therapeutic response of absence seizures in patients of an epilepsy clinic for adolescents and adults.  J Neurol. 1984;  231 225-229
    PubMedGoogle Scholar

Correspondence

Bernhard Schmitt

University Children's Hospital

Clinical Neurophysiology

Steinwiesstrasse 75

8032 Zurich

Switzerland

Phone: +41/44/266 75 92

Fax: +41/44/266 71 65

Email: bernhard.schmitt@kispi.uzh.ch

      >